palmitoleic acid Report issue

Small molecule Experimental
AACT DrugBank MeSH PubChem

Active Ingredient History

NOW
  • Now
Palmitoleic acid, or (9Z)-hexadec-9-enoic acid, is an omega-7 monounsaturated fatty acid (16:1n-7) with the formula CH3(CH2)5CH=CH(CH2)7COOH. It is a rare component of fats. It is a common constituent of the glycerides of human adipose tissue. It is present in all tissues but, in general, found in higher concentrations in the liver.   Wikipedia

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: Missing data
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: Missing data

Alternative names

9-cis-hexadecenoic acid | 9-hexadecenoic acid | (9z)-hexadecenoic acid | c16:1n7 | c16:1 trans-9 | cis-9-hexadecenoic acid | palmitelaidic acid | palmitoleate | palmitoleic acid | palmitoleic acid, (e)-isomer | palmitoleic acid, potassium salt, (z)-isomer | palmitoleic acid, sodium salt, (z)-isomer | palmitoleic acid, (z)-isomer | palmitolinoleic acid | (z)-9-hexadecenoic acid | (z)-hexadec-9-enoic acid | zoomaric acid

Organizations (5)

Research & Development (5)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (3)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (3)


 

Cardiovascular Diseases (Phase 2)

Colitis, Ulcerative (Early Phase 1)

Inflammatory Bowel Diseases (Early Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 5
  • # of Trial Organizations: 5

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue